Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms

Diabetes Care

Volumn 29, Issue 9, 2006, Pages 2053-2057

  Thamotharampillai, Keerthi ^a   Chan, Albert K F ^a   Bennetts, Bruce ^a,b   Craig, Maria E ^a,b,c   Cusumano, Janine ^a   Silink, Martin ^a,b   Oates, Peter J ^d   Donaghue, Kim C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; HEMOGLOBIN A1C;

ADOLESCENT; ADOLESCENT DISEASE; ALLELE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BREATHING; CARDIOVASCULAR PARAMETERS; CHILD; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NERVE FUNCTION; NEUROPHYSIOLOGY; PUPILLOMETRY; SENSORY NERVE; STATISTICAL ANALYSIS; THERMAL ANALYSIS; VIBRATION;

ADOLESCENT; ALDEHYDE REDUCTASE; ALLELES; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 1; DINUCLEOTIDE REPEATS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART RATE; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; REFLEX, PUPILLARY; VALSALVA MANEUVER;

EID: 33845288021     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0678     Document Type: Article

References (34)

1. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM: Diabetic somatic neuropathies (Review). Diabetes Care 27:1458-1486, 2004
2. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy (Review). Diabetes Care 26:1553-1579, 2003
3. Boulton AJ, Kirsner RS, Vileikyte L: Clinical practice: neuropathic diabetic foot ulcers. N Engl J Med 351:48-55, 2004
4. Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26:1895-1901, 2003
5. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122:561-568, 1995
6. Hyllienmark L, Brismar T, Ludvigsson J: Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia 38:685-692, 1995
7. Karachaliou F, Karavanaki K, Greenwood R, Baum JD: Consistency of pupillary abnormality in children and adolescents with diabetes. Diabet Med 14:849-853, 1997
8. Pena MM, Donaghue KC, Fung AT, Bonney M, Schwingshandl J, Howard NJ, Silink M: The prospective assessment of autonomic nerve function by pupillometry in adolescents with type 1 diabetes mellitus. Diabet Med 12:868-873, 1995
9. Donaghue KC, Margan SH, Chan AK, Holloway B, Silink M, Rangel T, Bennetts B: The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents. Diabet Med 22:1315-1320, 2005
10. Heesom AE, Millward A, Demaine AG: Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene. J Neurol Neurosurg Psychiatry 64:213-216, 1998
11. Sivenius K, Pihlajamaki J, Partanen J, Niskanen L, Laakso M, Uusitupa M: Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes. Diabetes Care 27:2021-2026, 2004
12. Dent MT, Tebbs SE, Gonzalez AM, Ward JD, Wilson RM: Neutrophil aldose reductase activity and its association with established diabetic microvascular complications. Diabet Med 8:439-442, 1991
13. Hamada Y, Kitoh R, Raskin P: Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes 40:1233-1240, 1991
14. Oates PJ: Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol 50:325-392, 2002
15. Demaine A, Cross D, Millward A: Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 41:4064-4068, 2000
16. Heesom AE, Hibberd ML, Millward A, Demaine AG: Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 46:287-291, 1997
17. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS: Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabet Med 17:111-118, 2000
18. Donaghue KC, Bonney M, Simpson JM, Schwingshandl J, Fung AT, Howard NJ, Silink M: Autonomic and peripheral nerve function in adolescents with and without diabetes. Diabet Med 10:664-671, 1993
19. Schwingshandl J, Simpson JM, Donaghue K, Bonney MA, Howard NJ, Silink M: Pupillary abnormalities in type I diabetes occurring during adolescence: comparisons with cardiovascular reflexes. Diabetes Care 16:630-633, 1993
20. Kao YL, Donaghue K, Chan A, Knight J, Silink M: A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes 48:1338-1340, 1999
21. Ko BC, Lam KS, Wat NM, Chung SS: An (A-C)n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 44:727-732, 1995
22. Kao YL, Donaghue K, Chan A, Knight J, Silink M: An aldose reductase intragenic polymorphism associated with diabetic retinopathy. Diabetes Res Clin Pract 46:155-160, 1999
23. Lajer M, Tarnow L, Fleckner J, Hansen BV, Edwards DG, Parving HH, Boel E: Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian type 1 diabetic patients. Diabet Med 21:867-873, 2004
24. Nakayama M, Nakamura J, Hamada Y, Chaya S, Mizubayashi R, Yasuda Y, Kamiya H, Koh N, Hotta N: Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy. Diabetes Care 24:1093-1098, 2001
25. Pittasch D, Lobmann R, Behrens-Baumann W, Lehnert H: Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care 25:1545-1550, 2002
26. Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, Dorin RI, Stidley C, Yacoub M, Vander Jagt DL, Eaton RP, Zager PG: Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab 83:2886-2891, 1998
27. Zou X, Lu J, Pan C: Effect of polymorphism of (AC)n in the 5′ end of aldose reductase gene on erythrocyte aldose reductase activity in patients with type 2 diabetes mellitus. Chinese J Endocrinol Metab 16:346-349, 2000
28. Hodgkinson AD, Sondergaard KL, Yang B, Cross DF, Millward BA, Demaine AG: Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy. Kidney Int 60:211-218, 2001
29. Yang B, Millward A, Demaine A: Functional differences between the susceptibility Z-2/C-106 and protective Z+2/T-106 promoter region polymorphisms of the aldose reductase gene may account for the association with diabetic microvascular complications. Biochim Biophys Acta 1639:1-7, 2003
30. Powell HC, Garrett RS, Kador PF, Mizisin AP: Fine-structural localization of aldose reductase and ouabain-sensitive, K(+)-dependent p-nitro- phenylphosphatase in rat peripheral nerve. Acta Neuropathol (Berl) 81:529-539, 1991
31. Mohsin F, Craig ME, Cusumano J, Chan AK, Hing S, Lee JW, Silink M, Howard NJ, Donaghue KC: Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. Diabetes Care 28:1974-1980, 2005
32. The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 46:1829-1839, 1997
33. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
34. Rogus JJ, Warram JH, Krolewski AS: Genetic studies of late diabetes complications: the overlooked importance of diabetes duration before complication onset. Diabetes 51:1655-1662, 2002